Karuna raises $68m to develop neurology drug KarXTKaruna Therapeutics has raised $68 million to further develop its neurology drug KarXT, which is in phase 2 Share XKaruna raises $68m to develop neurology drug KarXThttps://pharmaphorum.com/news/karuna-raises-68m-to-develop-neurology-drug-karxt/
PureTech to research Alzheimer’s drugs based on ‘brain drain’ theoryUS biotech PureTech Health is to develop therapies that are based on a new theory that neurological diseases Share XPureTech to research Alzheimer’s drugs based on ‘brain drain’ theoryhttps://pharmaphorum.com/news/puretech-research-alzheimers-brain-drain-theory/
